BioSpace News Archive

Akili Interactive announced that co-founder and Chief Executive Officer, Eddie Martucci, will participate in a panel discussion at SXSW 2022, a conference that convenes a global community of digital creatives with a shared pursuit of forward-thinking, cutting-edge ideas.

The global medical tourism market growth is expanding at a remarkable CAGR of around 10.8% during the forecast period 2021 to 2030 due to increased demand for the cheap treatment for various chronic diseases.

Increasing volumes of newborn screening tests to check for metabolic, genetic abnormalities, or developmental problems are expected to drive the global market revenue growth.

Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of refractive and retinal eye disorders, today announced that Mina Sooch, MBA, Founder and CEO will present a corporate overview at the Oppenheimer 32nd Annual Healthcare Conference.

Rising number of cancer cases worldwide and increasing spending by governments of various countries globally on cancer research & development are factors driving market revenue growth.

DepYmed, Inc. (“DepYmed” or the “Company”) and the Monash Biomedicine Discovery Institute (“Monash BDI”) at Monash University in Melbourne, Australia announce today that they have entered into a sponsored research agreement (SRA) to explore the potential of the Company’s drug development candidates to treat cancer by targeting a newly discovered intracellular immune checkpoint.

The industry analysis report is considered a valuable source of information about the global Valley Fever industry and lays stress on the future market scope, emerging industry trends, industry statistics, and market growth potential during the forecast years.

The global healthcare additive manufacturing market size is projected to surpass around US$ 9.87 billion by 2030 from valued at US$ 1.65 billion in 2021, growing at a CAGR of 22% from 2021 to 2030.

Applied DNA Sciences, Inc. (NASDAQ: APDN), announced today that Chief Executive Officer Dr. James A. Hayward will host a virtual fireside chat with the Company’s covering analyst, Managing Director and Senior Research Analyst Jonathan Aschoff, on Monday, March 14, 2022, at the 34th Annual ROTH Investor Conference.

Immunovia AB announced that the Annual Report for 2021 has been published.